IL6 and Alzheimer disease: In the AD model, Trem2 expression was suppressed, enhancing nuclear factor‐κB (NF‐κB) signaling and promoting the secretion of pro‐inflammatory factors such as tumor necrosis factor‐α (TNF‐α) and interleukin‐6 (IL‐6).